Recent Studies on Ponatinib in Cancers Other Than Chronic Myeloid Leukemia.

Musumeci, Francesca; Greco, Chiara; Grossi, Giancarlo; Molinari, Alessio; Schenone, Silvia

Musumeci, Francesca; Greco, Chiara; Grossi, Giancarlo; Molinari, Alessio; Schenone, Silvia.

Afiliación

Musumeci F; Department of Pharmacy, University of Genova, Viale Benedetto XV 3, 16132 Genova, Italy. francesca.musumeci@unige.it.
Greco C; Department of Pharmacy, University of Genova, Viale Benedetto XV 3, 16132 Genova, Italy. greco.phd@difar.unige.it.
Grossi G; Department of Pharmacy, University of Genova, Viale Benedetto XV 3, 16132 Genova, Italy. grossig@unige.it.
Molinari A; Department of Biotechnology, Chemistry and Pharmacy, University of Siena, Via Aldo Moro 2, 53100 Siena, Italy. molinari.a2@gmail.com.
Schenone S; Department of Pharmacy, University of Genova, Viale Benedetto XV 3, 16132 Genova, Italy. schenone@difar.unige.it.

Cancers (Basel) ; 10(11)2018 Nov 09.

Article en En | MEDLINE | ID: mdl-30423915

Palabras clave

cancer; ponatinib; protein kinase inhibitor

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cancers (Basel) Año: 2018 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google